Top August & September 2021 FDA Approvals
August and September 2021 FDA drug approvals include treatments for tick-borne encephalitis, idiopathic hypersomnia, schizophrenia, and atopic dermatitis.
Psoriasis Information Center
Secukinumab vs Adalimumab in Concomitant PsA and Plaque Psoriasis
Secukinumab vs adalimumab for treatment in patients with concomitant plaque psoriasis and active psoriatic arthritis during 52 weeks is reported.
Psoriatic Arthritis Worsens QoL in Psoriasis Patients
Individuals with psoriasis/PsA have decreased ability to participate in social roles and activities, more depression symptoms.
Guselkumab Shows Skin Clearance in Psoriasis, Joint Symptom Improvement in Psoriatic Arthritis
At AAD VMX 2021, researchers presented data on skin clearance rates through 5 years with guselkumab in patients with moderate to severe plaque psoriasis.
Bimekizumab Tops Secukinumab for Plaque Psoriasis
In moderate-to-severe plaque psoriasis, bimekizumab is noninferior and superior to secukinumab and adalimumab, according to data from 2 studies.
Premature Mortality Not Associated With Chronic or Increasing Pain Among Patients With Psoriatic Arthritis
Researchers sought to determine if a higher cumulative pain intensity is associated with premature mortality risk in patients with PsA.
Similar Rates of Depression and Anxiety Plus Depression With Apremilast vs Other Drugs in Psoriatic Arthritis
Apremilast used for the treatment of psoriasis or psoriatic arthritis is not associated with a high risk of incident treated depression, anxiety, or anxiety plus depression.
Real-World Study: Guselkumab May Be Effective for Moderate to Severe Plaque Psoriasis
Real-world data from patients with plaque psoriasis treated with guselkumab, who had previously been administered biologic agents is presented.
Psoriasis Increases Risk for Metabolic Syndrome and Coronary Plaque Burden
A novel study evaluated the effect of cardiometabolic syndrome on early vascular disease in patients with psoriasis.
PASI, BSA Involvement, and QoL Scales Best to Determine Psoriasis Severity
The correlation between physician-evaluated PASI and BSA involvement and patient-evaluated DLQI and PDI was evaluated in measuring psoriasis disease severity.
Weight Loss Linked to Reduced Disease Activity in Patients With Psoriatic Arthritis and Obesity
Researchers assessed the effects of weight loss on disease activity and cardiovascular risk factors in patients with psoriatic arthritis and obesity.
Subcutaneous Methotrexate vs Oral Treatment in Patients With Psoriasis
The effectiveness of oral vs subcutaneous methotrexate for the treatment of psoriasis in a registry is reported.
High IL-17 Levels Linked to Decreased Psoriatic Arthritis Risk
Researchers determined the causal associations between genetically predicted TNF-α, IL-12p70, and IL-17 levels and risk for psoriatic arthritis.
Psoriatic Arthritis and Rheumatoid Arthritis Have Similar Effect on Hand Function
Researchers compared the effect of psoriatic arthritis and rheumatoid arthritis on objective and subjective parameters of hand function.
Expert Roundtable: Racial Disparities in Dermatology Care
A roundtable discussion by experts in issues facing patients with skin of color reveals interesting insights.
Risk for Bone Fractures Up for Patients With Psoriatic Diseases
For adults with psoriatic diseases, the likelihood of developing bone fractures is increased, although they have no increased risk for osteoporosis.
Biologic Agent Use Associated With Lower Hospitalization Risk for Patients With Psoriasis and COVID-19
The course of COVID-19 in patients with psoriasis was characterized and factors associated with hospitalization were identified in an international case study.
Fibromyalgia in Psoriatic Arthritis Associated With Sleep Disturbances and Poor Quality of Life
Researchers evaluated the association between fibromyalgia in psoriatic arthritis and enthesopathy, sleep, fatigue, and quality of life.
Depression Common Among Psoriasis Patients
Researchers assessed the prevalence of pharmacologically treated depression among individuals with and without psoriasis.
Diabetes, CVD, and Mood Disorders Are Highly Prevalent in Patients With Palmoplantar Plaque Psoriasis
The relationship of palmoplantar plaque psoriasis and comorbidities known to be associated with generalized plaque psoriasis were examined.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Psoriasis Information Center
Loading... 
Loading...